Various nanomaterials have been developed that are capable of inducing cuproptosis [48,49], and utilizing these nanomaterials to enhance the expression of ts-MHC-II-HLA-DRA may offer a novel approach to augmenting anti-tumor immune responses. The gene discussed is HLA-DRA; the disease is neoplasm.